The Capital Requirements (Basel III) and the Banking Sector Business Activity

Active development by international organizations and national regulators of the emergent standards purporting prevention of crises and increase of banking stability is typical for the last years. However, practical implementation of the standards is not so definitive. This article is devoted to the analysis of impact of new requirements in the field of control over the quality and adequacy of the capital of banks, introduction of the additional parameters of risk-related load on the basis of financial leverage on business activity of banking sector.The issue of correlational study of capital adequacy ratio of banks and their credit activity was considered by different scientists over the last years; however, no decisive results were obtained. At the same time, the belief on the change of capital requirements and bank loans prevails. Generally, after strengthening of capital requirements, the banks reduce the loan growth. The authors of research prove this conclusion for the Russian economy.Following carried out analysis, the conclusion was also drawn that against the background of essential excess of the planned level of financial leverage, banks generated a highly risky asset portfolio, where the new standard did not address. It is the authors' opinion that for the purpose of impact on financial activity, the leverage levels must be differential for banks having various business models

ASSESSMENT OF THE EFFICACY OF COMBINED EFFECT IMMUNOMODULATOR INOSINE PRANOBEX IN PREVENTING RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGIES

Among children with allergies, particularly with bronchial asthma, patients susceptible to frequent acute respiratory infections make up a large group. In recent years, a strong focus has been on persistency of viruses and other pathogenic microorganisms in various areas of the respiratory tract, which leads to change in responsiveness of the organism and warrants the practicability of applying agents with a combined immunomodulating and antiviral effect. The purpose of this study was to assess the clinical and immunological efficacy of inosine pranobex in children with bronchial asthma and frequent respiratory infections. 37 children with atopic persistent moderate asthma at ages 4 to 15 were examined, 26 of which were administered inosine pranobex orally in prevention dosages at 50 mg/kg twice a day over 14 days. The control group was made up of 11 children who were on no immunopharmacological prevention course. Virus antigens in nasopharyngeal smear samples were identified, cytokine status and antibody immune response were studied. In the main group, 23 children (88,5%) were found to have the frequency and length of intercurrent acute respiratory viral infections decreased 1,5 times (p < 0,05) and the number of asthma attacks decreased 1,7 times (p < 0,05). The obtained results demonstrate the efficacy of preventing respiratory infections with inosine pranobex in children with bronchial asthma and other allergic diseases. Key words: acute respiratory infections, allergy, bronchial asthma, children, prevention, immunomodulators, inosine pranobex. (Pediatric Pharmacology. – 2010; 7(5):30-37

CLINICAL AND IMMUNOLOGICAL EFFICACY OF INOSINE PRANOBEX FOR ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH ATOPIC ASTHMA

The prevalence rate of atopic asthma in children remains high. One of the reasons for lack of control over asthma symptoms is repeated infection. The article describes results from the study of immunomodulating medication inosine pranobex used in treatment of acute respiratory infections in children with atopic asthma. The results obtained prove the efficacy and safety of this medication. The use of this immunomodifier with antiviral activity during the period of acute respiratory infection in children with atopic asthma contributes to shortening of intoxication and catarrhal signs duration, elimination of viral agents. Key words: asthma, acute respiratory infections, immunomodifiers, inosine pranobex, children. (Pediatric Pharmacology. – 2010; 7(3):98-105

CLINICAL AND IMMUNOLOGICAL EFFICACY OF INOSINE PRANOBEX FOR ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH ATOPIC ASTHMA

The prevalence rate of atopic asthma in children remains high. One of the reasons for lack of control over asthma symptoms is repeated infection. The article describes results from the study of immunomodulating medication inosine pranobex used in treatment of acute respiratory infections in children with atopic asthma. The results obtained prove the efficacy and safety of this medication. The use of this immunomodifier with antiviral activity during the period of acute respiratory infection in children with atopic asthma contributes to shortening of intoxication and catarrhal signs duration, elimination of viral agents. Key words: asthma, acute respiratory infections, immunomodifiers, inosine pranobex, children. (Pediatric Pharmacology. – 2010; 7(3):98-105

Balliranoite, (Na,K)6Ca2(Si6Al6O24)Cl2(CO3), a new cancrinite-group mineral from Monte Somma - Vesuvio volcanic complex, Italy

The new cancrinite-group mineral balliranoite was found in a metasomatic rock from Monte Somma – Vesuvio volcanic complex, Campania, Italy. Associated minerals are orthoclase, phlogopite, clinohumite, calcite, diopside, pargasite, hau¨yne and apatite. The mineral is named for the Italian crystallographer Paolo Ballirano. Balliranoite is transparent, colourless. It occurs in the cavities of the rock as coarse prismatic crystals up to 1 1 2mmand as anhedral grains up to 1 cmin the groundmass. The mineral is brittle, with Mohs hardness 5 and perfect cleavage on (10-10). Dmeas is 2.48(1), Dcalc is 2.486(12) g/cm3. Optically, the new mineral is uniaxial (þ), o ¼ 1.523(2), e ¼ 1.525(2). IR spectrum is given. The chemical composition is (mean of 5 analyses, wt%): Na2O 13.05, K2O 3.08, CaO 12.70, Al2O3 27.28, SiO2 32.38, SO3 1.96, Cl 7.43, –O¼Cl2 1.68; CO2 (determined by selective sorption of ignition products) 3.24; H2O (determined by Penfield method) 0.19; total 99.63. The empirical formula based on 12 (Si þ Al) is: Na4.70Ca2.53K0.73(Si6.02Al5.98O23.995)Cl2.34(CO3)0.82(SO4)0.270.12H2O. The simplified formula is: Na5KCa2(Si6Al6O24)Cl2(CO3). The crystal structure was refined (R ¼ 0.0396). Balliranoite is hexagonal, P63; a ¼ 12.695(2) A ˚ , c ¼ 5.325(1) A ˚ , V ¼ 743.2(2) A ˚ 3, Z ¼ 1. Balliranoite is an analogue of cancrinite with . . .–Ca–Cl–Ca–Cl–. . . chains in narrow channels instead of . . .–Na–H2O–Na–H2O–. . . and an analogue of davyne with prevailing of (CO3) in the broad channels instead of (SO4). The strongest lines of the powder diffraction pattern [d, A˚ (I, %) (hkl)] are: 4.797 (100) (101), 3.669 (57) (300), 3.281 (73) (211), 2.754 (16) (400), 2.662 (58) (002), 2.446 (31) (401), 2.120 (18) (330). The holotype specimen is deposited in Fersman Mineralogical Museum of Russian Academy of Sciences, Moscow, Russia, with the registration number 3756/1

ARE THE ANTIBIOTICS ALWAYS NECESSARY FOR THE TREATMENT OF THE CHRONIC COUGH AMONG CHILDREN?

Cough is one of the main symptoms for the impairment of the respiratory passages. Nonetheless, cough may usually appear along with the development of a pathological process in other organs and systems. Authors point to the importance of its correct estimate for the differential diagnosis. They have examined the reasons for the cough among children, depending on the age of a child, related symptoms, duration and other properties of the cough itself. They studied etiological structure of diseases, in the course of which such a symptom comes to existence. They also analyzed the detection rate of the viral and intracellular causative agents in the aspirates among chronically coughing children, as well as the indicators of the humoral immunity to the intracellular causative agents. Besides, the article deals with the questions of the adequate antibechic therapy.Key words: cough, etiology, pathogenesis, differential diagnosis, viruses, intracellular causative agents, treatment, children

New Data on Fiedlerite-1A from Ancient Slags of Lavrion, Greece: Crystal Structure and Hydrogen Bonding

Abstract: The crystal structure (R = 0.0750) of fiedlerite-1A Pb3Cl4F (OH) · H2O from ancient slags of Lavrion (Greece) was studied on a single crystal. The mineral is triclinic, a = 8.5741 (7) Å, b = 8.0480 (5) Å, c = 7.2695 (4) Å, α = 90.087 (5), β = 102.126 (6), γ = 103.424 (6)°, V = 476.37 (6) Å3, Z = 2. The Pb2+ cations center the Pb(1)F(H2O)Cl6, Pb(2)(OH)2FCl5, and Pb(3)(OH)F2Cl5 bicapped trigonal prisms. In the structure there is an additional position Pb', filled by 10% with Pb2+. There are two main structural fragments alternating along the a axis: (100) layers of Pb(2)- and Pb(3)-centred polyhedra and zigzag chains, stretched along the b axis formed by Pb(1)-centred polyhedra sharing common edges. The IR spectrum of fiederlite-1A is given. © 2019, Pleiades Publishing, Ltd

CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF THE INTERFERON SYNTHESIS INDUCTOR AMONG CHILDREN, SUFFERING FROM THE ACUTE RESPIRATORY INFECTIONS WITH THE ALLERGIC PATHOLOGY

This work presents research findings of the tiloron interferon synthesis application among children, suffering from the allergy and acute respiratory viral infections, witnessing its efficiency and safety. The use of tiloron against the acute respiratory diseases among children with the allergy contributes to much easier run of the viral infection, prevents the exacerbation of the main disease and stimulates the generation of the endogenic interferon.Key words: children, allergic diseases, acute respiratory Viral infections, interferon, tiloron

CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF THE INTERFERON SYNTHESIS INDUCTOR AMONG CHILDREN, SUFFERING FROM THE ACUTE RESPIRATORY INFECTIONS WITH THE ALLERGIC PATHOLOGY

This work presents research findings of the tiloron interferon synthesis application among children, suffering from the allergy and acute respiratory viral infections, witnessing its efficiency and safety. The use of tiloron against the acute respiratory diseases among children with the allergy contributes to much easier run of the viral infection, prevents the exacerbation of the main disease and stimulates the generation of the endogenic interferon.Key words: children, allergic diseases, acute respiratory Viral infections, interferon, tiloron